BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32524461)

  • 1. Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis.
    Hoendervangers S; Burbach JPM; Lacle MM; Koopman M; van Grevenstein WMU; Intven MPW; Verkooijen HM
    Ann Surg Oncol; 2020 Oct; 27(11):4319-4336. PubMed ID: 32524461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Locally Advanced Rectal Cancer in the Era of Total Neoadjuvant Therapy: A Systematic Review and Network Meta-Analysis.
    Turri G; Ostuzzi G; Vita G; Barresi V; Scarpa A; Milella M; Mazzarotto R; Ruzzenente A; Barbui C; Pedrazzani C
    JAMA Netw Open; 2024 Jun; 7(6):e2414702. PubMed ID: 38833249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
    An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
    Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review.
    Manatakis DK; Gouvas N; Souglakos J; Xynos E
    Int J Clin Oncol; 2020 Sep; 25(9):1570-1580. PubMed ID: 32666388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fluoropyrimidine and Oxaliplatin-based Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Okada Y; Ozawa T; Hayama T; Ohno K; Tsukamoto M; Fukushima Y; Shimada R; Nozawa K; Matsuda K; Hashiguchi Y
    In Vivo; 2021; 35(1):593-601. PubMed ID: 33402514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
    Liu S; Jiang T; Xiao L; Yang S; Liu Q; Gao Y; Chen G; Xiao W
    Oncologist; 2021 Sep; 26(9):e1555-e1566. PubMed ID: 33987952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
    Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
    Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the addition of oxaliplatin to single agent fluoropyrimidine in the treatment of locally advanced rectal cancer: a systematic review and meta-analysis.
    Thavaneswaran S; Kok PS; Price T
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):965-979. PubMed ID: 28819989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis.
    Yang YJ; Cao L; Li ZW; Zhao L; Wu HF; Yue D; Yang JL; Zhou ZR; Liu SX
    Oncotarget; 2016 Jul; 7(29):45513-45524. PubMed ID: 27322422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
    Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
    Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial).
    Kondo K; Matsusaka S; Ishihara S; Horie H; Uehara K; Oguchi M; Murafushi K; Ueno M; Mizunuma N; Shimbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Fujii M; Nakajima T
    Radiother Oncol; 2019 May; 134():199-203. PubMed ID: 31005216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant short-course radiotherapy with consolidation chemotherapy for locally advanced rectal cancer: a systematic review and meta-analysis.
    Patel A; Spychalski P; Corrao G; Jereczek-Fossa BA; Glynne-Jones R; Garcia-Aguilar J; Kobiela J
    Acta Oncol; 2021 Oct; 60(10):1308-1316. PubMed ID: 34308767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation of preoperative short-course radiotherapy followed by neoadjuvant chemotherapy in locally advanced rectal cancer: protocol for an open-label, single-centre, phase I clinical trial.
    Zhang MX; Li XB; Guan BJ; Guan GX; Lin XY; Wu XD; Chi P; Xu BH
    BMJ Open; 2019 Mar; 9(3):e025944. PubMed ID: 30904869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 18. PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer.
    Sclafani F; Brown G; Cunningham D; Wotherspoon A; Tait D; Peckitt C; Evans J; Yu S; Sena Teixeira Mendes L; Tabernero J; Glimelius B; Cervantes A; Thomas J; Begum R; Oates J; Chau I
    Ann Oncol; 2016 Aug; 27(8):1557-65. PubMed ID: 27217542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.
    Jalil O; Claydon L; Arulampalam T
    J Gastrointest Cancer; 2015 Sep; 46(3):219-36. PubMed ID: 26133151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial.
    Zwart WH; Temmink SJD; Hospers GAP; Marijnen CAM; Putter H; Nagtegaal ID; Blomqvist L; Kranenbarg EM; Roodvoets AGH; Martling A; van de Velde CJH; Glimelius B; Peeters KCMJ; van Etten B; Nilsson PJ;
    Eur J Cancer; 2024 Jun; 204():114044. PubMed ID: 38636289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.